Lirentelimab
- Generic Name
- Lirentelimab
- Drug Type
- Biotech
- CAS Number
- 2283348-97-8
- Unique Ingredient Identifier
- SWS48LJU3T
- Background
Lirentelimab is under investigation in clinical trial NCT04856891 (A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis).
A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Allakos Inc.
- Target Recruit Count
- 47
- Registration Number
- NCT03436797
- Locations
- 🇩🇪
Allakos Investigational Site, Mainz, Germany
A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
Phase 1
Completed
- Conditions
- Perennial Allergic ConjunctivitisAtopic KeratoconjunctivitisVernal Keratoconjunctivitis
- First Posted Date
- 2017-12-20
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- Allakos Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03379311
- Locations
- 🇺🇸
Riverside Clinical Research, Edgewater, Florida, United States
🇺🇸Byers Eye Institute at Stanford University, Palo Alto, California, United States
🇺🇸Ophthalmology Associates, Saint Louis, Missouri, United States
Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AK002 in Healthy Participants
- First Posted Date
- 2016-08-09
- Last Posted Date
- 2017-09-26
- Lead Sponsor
- Allakos Inc.
- Target Recruit Count
- 51
- Registration Number
- NCT02859701
- Locations
- 🇦🇺
Nucleus Network Limited, Melbourne, Australia
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002
- First Posted Date
- 2016-06-22
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Allakos Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT02808793
- Locations
- 🇩🇪
Charité - Universitätsmedizin Berlin, Berlin, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath